BCAX Bicara Therapeutics Inc.

Fundamentals / CIK 0002023658 / USD

Bicara Therapeutics Inc. reported $460.6M in total assets and a net loss of $220.3M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BCAX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$129.0MFY 2023 Net Income: -$51.98M2023FY 2024 Net Income: -$68.00M2024FY 2025 Net Income: -$137.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development -- $63.60M $30.60M
Total Operating Expenses $155.6M $82.39M $39.89M
Operating Income -$155.6M -$82.39M -$39.89M
EBITDA -$155.5M -$82.33M -$39.87M
Interest Income $17.87M $14.58M $1.31M
Income Before Tax -$137.7M -$67.81M -$51.98M
Income Tax Expense $217K $187K $5.0K
Net Income -$137.9M -$68.00M -$51.98M
Basic EPS -$2.52 -$4.05 -$89.61
Diluted EPS -$2.52 -$4.05 -$89.61
Basic Shares Outstanding 54.68B 16.81B 580.1M
Diluted Shares Outstanding 54.68B 16.81B 580.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development -- -- -- -- $33.00M $24.80M $34.30M $19.90M
Total Operating Expenses $75.71M $59.95M $60.24M $41.12M $40.68M $32.02M $41.79M $26.64M
Operating Income -$75.71M -$59.95M -$60.24M -$41.12M -$40.68M -$32.02M -$41.79M -$26.64M
EBITDA -$75.65M -$59.91M -$60.20M -$41.08M -$40.65M -$32.00M -$41.77M -$26.62M
Interest Income $4.52M $4.58M $4.08M $3.79M $4.39M $4.68M $5.01M $5.87M
Income Before Tax -$71.19M -$55.38M -$56.16M -$37.33M -$36.29M -$27.34M -$36.77M -$20.77M
Income Tax Expense $54K $61K $52K $53K $40K $52K $72K $186K
Net Income -$71.25M -$55.44M -$56.21M -$37.39M -$36.33M -$27.39M -$36.85M -$20.96M
Basic EPS -$1.04 -$0.82 -$0.93 -- -$0.67 -$0.50 -$0.68 --
Diluted EPS -$1.04 -$0.82 -$0.93 -- -$0.67 -$0.50 -$0.68 --
Basic Shares Outstanding 68.4M 67.9M 60.7M -- 54.6M 54.5M 54.5M --
Diluted Shares Outstanding 68.4M 67.9M 60.7M -- 54.6M 54.5M 54.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $96.69M $489.7M $230.4M
Short-Term Investments $318.1M $0 --
Cash & Short-Term Investments $414.8M $489.7M $230.4M
Total Current Assets $422.1M $502.5M $231.1M
Property, Plant & Equipment, Net $330K $155K $202K
Long-Term Investments -- $0 --
Other Non-Current Assets $6.91M $6.62M $2.09M
Total Non-Current Assets $8.94M $7.46M $2.91M
Total Assets $431.0M $510.0M $234.0M
Total Current Liabilities $28.95M $17.99M $15.09M
Other Non-Current Liabilities -- $0 $17K
Total Non-Current Liabilities $593K $131K $389K
Total Liabilities $29.54M $18.12M $15.47M
Total Debt (incl. Leases) $1.71M $738K $657K
Common Stock $7.0K $7.0K $2.0K
Retained Earnings -$359.0M -$221.0M -$153.0M
Accumulated Other Comp. Income $243K $0 --
Total Stockholders' Equity $401.5M $491.9M -$148.8M
Total Equity $401.5M $491.9M -$148.8M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $82.02M $96.60M $323.5M $96.69M $171.7M $436.6M $462.1M $489.7M
Short-Term Investments $360.3M $400.7M $216.3M $318.1M $118.5M -- -- $0
Cash & Short-Term Investments $442.3M $497.3M $539.8M $414.8M $290.2M $436.6M $462.1M $489.7M
Total Current Assets $451.4M $503.8M $544.9M $422.1M $297.4M $444.4M $470.8M $502.5M
Property, Plant & Equipment, Net $965K $362K $346K $330K $135K $117K $136K $155K
Long-Term Investments -- -- -- -- $117.4M -- -- $0
Other Non-Current Assets $7.54M $6.91M $6.91M $6.91M $7.79M $6.84M $6.63M $6.62M
Total Non-Current Assets $9.23M $8.42M $8.68M $8.94M $127.3M $9.20M $7.32M $7.46M
Total Assets $460.6M $512.2M $553.6M $431.0M $424.7M $453.6M $478.1M $510.0M
Total Current Liabilities $51.23M $43.48M $39.34M $28.95M $21.03M $17.23M $19.12M $17.99M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 $301K $593K $880K $1.16M $0 $131K
Total Liabilities $51.23M $43.48M $39.64M $29.54M $21.91M $18.39M $19.12M $18.12M
Total Debt (incl. Leases) $880K $1.16M $1.44M $1.71M $1.98M $2.24M $591K $738K
Common Stock $8.0K $8.0K $8.0K $7.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$541.9M -$470.6M -$415.2M -$359.0M -$321.6M -$285.2M -$257.9M -$221.0M
Accumulated Other Comp. Income -$1.87M -$567K -$243K $243K -$136K -- -- $0
Total Stockholders' Equity $409.4M $468.8M $514.0M $401.5M $402.8M $435.2M $459.0M $491.9M
Total Equity $409.4M $468.8M $514.0M $401.5M $402.8M $435.2M $459.0M $491.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$137.9M -$68.00M -$51.98M
Depreciation & Amortization $105K $56K $19K
Stock-Based Compensation $15.01M $7.40M $1.90M
Operating Cash Flow -$106.8M -$74.75M -$45.63M
Capital Expenditure -$280K -$71K -$586K
Free Cash Flow -$107.1M -$74.82M -$46.21M
Purchases of Investments -$318.2M $0 --
Investing Cash Flow -$318.5M -$9.0K -$586K
Common Stock Issued $29.50M $332.4M $0
Financing Cash Flow $32.26M $334.0M $272.5M
Net Change in Cash -$393.0M $259.3M $226.3M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$71.25M -$55.44M -$56.21M -$37.39M -$36.33M -$27.39M -$36.85M -$20.96M
Depreciation & Amortization $60K $44K $44K $43K $24K $19K $19K $15K
Stock-Based Compensation $9.98M $8.24M $5.86M $4.45M $3.61M $3.49M $3.45M $3.18M
Operating Cash Flow -$56.13M -$44.21M -$37.51M -$23.89M -$29.25M -$25.59M -$28.11M -$30.03M
Capital Expenditure -$663K -$60K -$60K -$238K -$42K $0 $0 -$40K
Free Cash Flow -$56.79M -$44.27M -$37.57M -$24.12M -$29.29M -$25.59M -$28.11M -$30.07M
Sales & Maturities of Investments $39.00M $60.00M $101.0M -- $0 $0 $0 --
Investing Cash Flow $38.34M -$185.0M $100.9M -$82.33M -$236.1M $0 $0 -$40K
Common Stock Issued $0 $0 $161.8M $29.50M $0 $0 $0 --
Financing Cash Flow $3.21M $2.33M $163.3M $31.23M $436K $135K $460K -$975K
Net Change in Cash -$14.58M -$226.9M $226.8M -$74.99M -$264.9M -$25.46M -$27.65M -$31.05M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -34.4% -13.8% --
Return on Assets (ROA) -32.0% -13.3% -22.2%
Current Ratio 14.58x 27.93x 15.32x
Quick Ratio 14.33x 27.22x 15.28x
Debt to Equity 0.00x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -53.8% -39.5% -30.6% -34.4% -30.2% -23.6% -20.1% -13.8%
Return on Assets (ROA) -47.8% -36.2% -28.4% -32.0% -28.6% -22.6% -19.3% -13.3%
Current Ratio 8.81x 11.59x 13.85x 14.58x 14.14x 25.80x 24.62x 27.93x
Quick Ratio 8.63x 11.44x 13.72x 14.33x 13.80x 25.34x 24.17x 27.22x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0002023658) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal